ELV vs ESPR · P/E 18, rev $199.13B vs rev $332.3M
Elevance Health Inc (ELV) versus Esperion Therapeutics Inc (ESPR) — a side-by-side from cached financials, not a winner call.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
Latest reported ESPR revenue for 2024-12-31 was $332.3M. Net income was -$51.7M. Revenue was up 185.7% from 2023-12-31 to 2024-12-31. ESPR currently screens at market cap $816.9M.
ELV currently screens at market cap $90.24B and trailing P/E 17.6. ESPR currently screens at market cap $816.9M.
Not investment advice. Open the ELV and ESPR stock pages for the full models.
Not investment advice.